The rising popularity of weight loss drugs is a key reason healthcare company Eli Lilly ( LLY 1.31%) has been soaring in ...
Money Talks News on MSN
Weight-loss drug Mounjaro reverses health benefits when you stop taking it, study finds
New research shows stopping Mounjaro causes rapid weight regain and reverses health improvements like lower blood pressure ...
The panel will host a Question and Answer session exploring the science behind the stories, and looking at whether the jabs ...
Eli Lilly leads in the GLP-1 drug space with its shot-based offerings Mounjaro and Zepbound. Rival drugmaker Novo Nordisk has ...
"I want to be here for a long time, and I want to look my best," the the actress said of using a GLP-1 to combat menopause ...
MoneyShow presents top investment ideas for 2026 from leading advisors. Part 4 includes Eli Lilly, Enterprise Products ...
Momentum in weight-loss drugs is the main reason why Eli Lilly's stock soared in 2025. Over the last five years it is up 459%, and that is excluding dividends. It is the largest drugmaker in the world ...
Pharmaceutical companies are paying thousands of Indiana doctors to talk about GLP-1 drugs, a WRTV Investigation has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback